about
Charcot-Marie-Tooth-linked mutant GARS is toxic to peripheral neurons independent of wild-type GARS levelsAlternative splicing events are a late feature of pathology in a mouse model of spinal muscular atrophyCrystal structure of human wildtype and S581L-mutant glycyl-tRNA synthetase, an enzyme underlying distal spinal muscular atrophyFrequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional studyThe contribution of mouse models to understanding the pathogenesis of spinal muscular atrophyMimics and chameleons in motor neurone diseaseGARS axonopathy: not every neuron's cup of tRNAA two-stage genome-wide association study of sporadic amyotrophic lateral sclerosisIncreased functional connectivity common to symptomatic amyotrophic lateral sclerosis and those at genetic riskAn eye-tracking version of the trail-making testPathogenesis of FUS-associated ALS and FTD: insights from rodent modelsHot-spot residue in small heat-shock protein 22 causes distal motor neuropathyNEK1 variants confer susceptibility to amyotrophic lateral sclerosisChondrolectin affects cell survival and neuronal outgrowth in in vitro and in vivo models of spinal muscular atrophyProgressive ataxia and palatal tremor associated with dense pontine calcification: A unique case.Myelin imaging in amyotrophic and primary lateral sclerosis.Eye-tracking in amyotrophic lateral sclerosis: A longitudinal study of saccadic and cognitive tasksTDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy.Biomarkers in amyotrophic lateral sclerosis.T₂-weighted MRI detects presymptomatic pathology in the SOD1 mouse model of ALS.Trk receptor signaling and sensory neuron fate are perturbed in human neuropathy caused by Gars mutations.A blinded international study on the reliability of genetic testing for GGGGCC-repeat expansions in C9orf72 reveals marked differences in results among 14 laboratories.What's new in the molecular genetics of spinal muscular atrophy?Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis.Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations.Novel SPG11 mutations in Asian kindreds and disruption of spatacsin function in the zebrafishCompound heterozygosity for loss-of-function lysyl-tRNA synthetase mutations in a patient with peripheral neuropathy.Corpus callosum involvement is a consistent feature of amyotrophic lateral sclerosisMutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy.Amyotrophic lateral sclerosis: cell vulnerability or system vulnerability?Protocol for diaphragm pacing in patients with respiratory muscle weakness due to motor neurone disease (DiPALS): a randomised controlled trial.Neuromuscular junction maturation defects precede impaired lower motor neuron connectivity in Charcot-Marie-Tooth type 2D micePredictors of cognitive impairment in an early stage Parkinson's disease cohortSystemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy.Severe childhood SMA and axonal CMT due to anticodon binding domain mutations in the GARS gene.Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial.Pattern of spread and prognosis in lower limb-onset ALS.Rasch analysis of the hospital anxiety and depression scale (HADS) for use in motor neurone disease.A recurrent loss-of-function alanyl-tRNA synthetase (AARS) mutation in patients with Charcot-Marie-Tooth disease type 2N (CMT2N)Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis.
P50
Q21144936-45DB0401-4126-4BDE-9F1B-68756FF654C5Q21144988-541FBEB8-D014-4BBB-BA24-494541D9E1F3Q24307723-CE5995B4-6812-4CCF-8AC3-04798EF99DF1Q24600803-4909D7C3-BDFD-4693-80B3-8C2596FFFC78Q24604444-6612E35C-B72E-4890-8EB4-802F16F862D7Q24619538-E2A40240-184B-4D8A-95E1-CC9FE499B654Q24647184-D675DA84-A542-4F56-98C7-B9F45339DEA5Q24648667-A03A0C5C-4951-4A0E-9BF1-C03A268D42BAQ24658568-07C402B0-7DB4-4EB6-A715-AB1F2CBE0A3AQ27335900-36764AE4-2764-4161-82B3-3FFFED75569FQ28067147-35D8E929-61A3-4D9E-9915-92AF5C692DC1Q28259704-9B6150EE-4EE1-4F4F-9B7C-795CE057E548Q28277378-26A0C3F8-5E98-41E4-B2BA-DB3A0CD6DD7DQ28506113-B5FE8732-6146-4104-B105-ECB7D50C6B8EQ30598870-024D73ED-9854-47B1-9DE6-519DD9918CC5Q30627110-3B7ED658-1D7E-470C-ADAE-45BD39278DDFQ30830145-95BC463F-65AE-4505-9706-DB00E8E6D59DQ33379948-8DCBC81D-F269-444F-89BE-70C6CB61A99EQ33392844-FA726FB2-05E0-4258-BA99-070570674533Q33581148-9AB18E1B-4BF6-4047-B9AC-5DF03A4C83E5Q33594799-C8EB31D0-E877-4EAE-9656-5BC6BCDADC3DQ33658563-CF5D26B5-41FF-448B-A43F-76061CEC4432Q33869830-9F05C464-8B5A-4A50-BE99-55A307066C5DQ34044019-BAE4CE9C-46F7-4F7B-BC32-2FA3B211D757Q34099212-2C674ECE-2C7B-4B89-B5AD-0B7E22D4F844Q34152696-C3742CDB-3BAF-49ED-B236-938F0AE3D321Q34169437-838CB33A-5F4A-481D-B6E6-2A6DBA3DA8D9Q34281282-49EBC8C6-86FF-4118-83F1-1129F034BADCQ34318026-E76340C5-536B-4278-989E-79898DCFB05DQ34369125-89255C26-EC0F-42C1-ADA5-FF8C8A57D136Q34381673-3362B182-A019-43FB-BE28-922066CD60B1Q34394330-700C66C8-75F6-43FB-B8B3-6BB7D97892E5Q34531319-C746EB66-D887-4040-8DD8-AEDBAA470471Q34540158-A0D84F4A-B7C9-43C5-A3AE-11087D07CC18Q34581366-436061BA-CE30-49CE-8250-6D09AB320E09Q34648924-BBB3A325-4016-43E4-AF68-37E723820648Q35239043-AB612CE0-6267-4A32-9E06-5C252ABFF464Q35338089-70145C92-2315-47AD-88C1-68830A694953Q35618883-0FF85A06-345A-4EB0-8AE5-83FC103B7A24Q35686186-6EADC999-CECB-4E33-A0DB-5FB6C2A6BC8E
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
K Talbot
@ast
K Talbot
@en
K Talbot
@es
K Talbot
@nl
type
label
K Talbot
@ast
K Talbot
@en
K Talbot
@es
K Talbot
@nl
altLabel
Kevin Talbot
@en
prefLabel
K Talbot
@ast
K Talbot
@en
K Talbot
@es
K Talbot
@nl
P214
P244
P106
P1153
55624775700
P214
P244
n2007063171
P31
P4012
P496
0000-0001-5490-1697
P734
P7859
lccn-n2007063171